On May 16, 2025, at the Vietnam Science and Technology Day 18-5 symposium organized by the Ministry of Science and Technology, Bidiphar received distinguished recognition for its exceptional contributions to pharmaceutical research and development in the field of advanced therapeutics.
Bidiphar Recognized for Breakthrough Achievements in Oncology Therapeutics
During a formal ceremony conducted at the plenary hall of Building B, Ministry of Science and Technology headquarters (18 Nguyen Du Street, Hanoi), the Chief Executive Officer of Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) was honored in the presence of senior government officials and scientific dignitaries.
The Ministry of Science and Technology acknowledged Bidiphar’s remarkable team achievement in the research, development, and clinical implementation of Vietnam’s first domestically manufactured oncology therapeutics. This milestone represents the culmination of sustained scientific inquiry, biotechnological innovation, and pharmaceutical engineering, all directed toward enhancing therapeutic outcomes for Vietnamese oncology patients.
Bidiphar’s Pioneering Advancements in Oncology Therapeutics
Currently, Bidiphar stands as the proprietor of Vietnam’s most comprehensive oncology pharmaceutical manufacturing facility, equipped with state-of-the-art GMP-certified production lines, advanced quality control laboratories, and cutting-edge research infrastructure. The company maintains market leadership in domestically manufactured antineoplastic agents and targeted therapies.
With an unwavering commitment to pharmaceutical excellence and therapeutic accessibility, Bidiphar has successfully facilitated nationwide access to high-efficacy oncology medications with optimized pharmacoeconomic profiles. This initiative has significantly reduced the financial burden associated with oncological treatment regimens, while simultaneously affirming the research capabilities and manufacturing prowess of Vietnamese pharmaceutical enterprises on the international stage.
Contributing to National Scientific and Technological Development
This year’s Vietnam Science and Technology Day 18-5 was conducted under the theme: “Science, Technology, Innovation, and Digital Transformation: Breakthrough Pathways toward a Prosperous and Powerful Nation.” Bidiphar’s achievements serve as a compelling demonstration of Vietnamese enterprises’ contributions to national development through applied scientific research and technological innovation.
Bidiphar remains committed to substantial investments in research and development, continuous enhancement of pharmaceutical manufacturing technologies, and expansion of its oncological therapeutic portfolio. These efforts align with the company’s mission to elevate healthcare standards for Vietnamese citizens while pursuing international recognition in pharmaceutical excellence.
About Bidiphar
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) ranks among Vietnam’s premier pharmaceutical enterprises, with over 45 years of industry expertise. The company specializes in the manufacturing and distribution of high-quality pharmaceutical products, with particular emphasis on oncology therapeutics. Supported by a team of leading pharmaceutical scientists and state-of-the-art facilities, Bidiphar persistently pursues research and development of novel therapeutic agents to address the evolving healthcare requirements of the population.
